Urogen Pharma Ltd (URGN)

Cash & Equivalents

$79.13M

Quarterly · Period ending: · USD

URGN logo

URGN Cash & Equivalents

Latest reported$79.13M
URGN Quarterly Cash & Equivalents ($3.87M → $79.13M)
High-resolution chart · PNG

URGN cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
79,133,000
111,295,000
110,745,000
90,039,000
92,904,000
104,033,000
171,987,000
124,916,000
219,972,000
132,262,000
95,823,000
119,305,000
20,127,000
36,540,000
55,408,000
28,686,000
80,690,000
105,379,000
44,360,000
55,337,000
63,322,000
40,492,000
52,864,000
24,565,000
36,350,000
26,468,000
49,688,000
66,147,000
90,424,000
246,692,000
101,318,000
109,483,000
119,109,000
127,460,000
36,999,000
79,171,000
77,093,000
-21,362,000
21,362,000
8,206,000
-15,070,000
15,070,000
17,975,000
-3,870,000
3,870,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.